Gopaldas Visram is a finished-dose manufacturer based in Nigeria. It appears in 79 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), FDA (GH) and MINSA (CR). Its GMP standing is certified by NAFDAC (NG), US FDA and FDA (GH). Its most recent recorded inspection, by US FDA, closed on 24 January 2025 as VAI. Customs aggregates show $12.5M of exports covering 903 molecules to 10 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Navi Mumbai, India | 3009565091 |
| THANE MAHARASHTRA STATE, Nigeria | Not on file |
| Navi Mumbai India, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 30 | 3 |
| FDA (GH) | 17 | 1 |
| MINSA (CR) | 17 | None |
| ARCSA (EC) | 15 | None |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.6M | 4 |
| 2025 | Not reported | $12.5M | 10 |
| 2024 | Not reported | $9.5M | 9 |
| 2023 | Not reported | $5.5M | 7 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Gopaldas Visram comes back tiered against every other supplier able to file there.
Start for free